Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
1.260
-0.020 (-1.56%)
Nov 20, 2024, 4:00 PM EST - Market closed
Century Therapeutics Market Cap
Century Therapeutics has a market cap or net worth of $107.14 million as of November 21, 2024. Its market cap has increased by 1.85% in one year.
Market Cap
107.14M
Enterprise Value
-36.38M
1-Year Change
1.85%
Ranking
Category
Stock Price
$1.26
Market Cap Chart
Since the IPO on June 18, 2021, Century Therapeutics's market cap has decreased from $1.05B to $107.14M, a decrease of -89.81%. That is a compound annual growth rate of -48.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 108.84M | -45.21% |
| Dec 29, 2023 | 198.65M | -34.34% |
| Dec 30, 2022 | 302.54M | -65.09% |
| Dec 31, 2021 | 866.61M | -17.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eupraxia Pharmaceuticals | 109.04M |
| Adlai Nortye | 108.86M |
| INmune Bio | 107.98M |
| Leap Therapeutics | 106.38M |
| Inovio Pharmaceuticals | 106.36M |
| Tiziana Life Sciences | 105.54M |
| Quipt Home Medical | 105.52M |
| Cidara Therapeutics | 105.29M |